This facility is dedicated to manufacturing Cephalosporins and its combination products. It has the capacity to manufacture Solid and Liquid dosage forms of Cephalosporins. This facility houses a State-of-the-Art Pilot Plant for the manufacture of exhibit batches for Regulated Markets. This facility is approved by W.H.O. and currently caters to the needs of the Indian market.

 

FORM

CAPACITY /MONTH

APPROVALS

Oral Liquid –Bottles

0.56 million

WHO

Solid Dosage –Tables

51.0 million

WHO

Solid Dosage –Dry Syrup Powder (Bottles)

0.625 million

WHO